» Articles » PMID: 28607685

Concurrent and Mutations in Melanoma of Unknown Origin Presenting As a Breast Mass

Overview
Publisher Sage Publications
Specialty General Medicine
Date 2017 Jun 14
PMID 28607685
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metastases represent a small percentage of the malignancies affecting the breast, and only 5% of melanomas originate from non-cutaneous sites. Multiple genetic aberrations have been associated with the development of melanocytic lesions, including V600E mutation. Mutations in gene have also been related to the pathogenesis of multiple malignancies.

Purpose/method: This is the case of a 28-year-old female who presented with a tender, palpable mass in the upper outer quadrant of the right breast. Ultrasound showed a 1-cm solid mass, initially diagnosed as invasive ductal carcinoma on biopsy. During pre-operative workup, a second mass was identified and biopsied. Immunohistochemical stains performed on the second mass biopsy demonstrated that the neoplastic cells were positive for cytokeratin AE1/3, pan-melanoma, tyrosinase, and SOX-10 and negative for CK7, CAM5.2, and GATA-3. Subsequent workup showed widespread metastatic disease involving the liver, lungs, bones, and brain. The brain metastasis tested positive for p.V600E and p.R130Efs*4 mutations. Thorough skin and eye examination did not reveal a primary melanoma.

Conclusion: Only few reports have been published of melanoma presenting as a breast mass. This is an interesting case due to the clinical presentation, diagnostic challenges, and genetic mutations profile.

Citing Articles

Comprehensive Literature Review on Melanoma of Unknown Primary Site Triggered by an Intriguing Case Report.

Bordeanu-Diaconescu E, Cretu A, Grosu-Bularda A, Andrei M, Hodea F, Dumitru C Diagnostics (Basel). 2024; 14(19).

PMID: 39410614 PMC: 11475773. DOI: 10.3390/diagnostics14192210.


The Evolution of BRAF Activation in Non-Small-Cell Lung Cancer.

Zhang L, Zheng L, Yang Q, Sun J Front Oncol. 2022; 12:882940.

PMID: 35912223 PMC: 9326470. DOI: 10.3389/fonc.2022.882940.


Malignant carcinoma and skin melanoma neoplasms concomitantly in the thyroid.

Al-Harake A, Dandache I, Moukadem H, Saliba M, Chahine J, Yazbeck H Clin Case Rep. 2021; 9(9):e04790.

PMID: 34552737 PMC: 8443434. DOI: 10.1002/ccr3.4790.

References
1.
Dahia P, Marsh D, Zheng Z, Zedenius J, Komminoth P, Frisk T . Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res. 1997; 57(21):4710-3. View

2.
Alva S . An update of tumor metastasis to the breast data. Arch Surg. 1999; 134(4):450. DOI: 10.1001/archsurg.134.4.450. View

3.
Aguissa-Toure A, Li G . Genetic alterations of PTEN in human melanoma. Cell Mol Life Sci. 2011; 69(9):1475-91. PMC: 11114653. DOI: 10.1007/s00018-011-0878-0. View

4.
Williams S, Ehlers 2nd R, Hunt K, Yi M, Kuerer H, Singletary S . Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer. 2007; 110(4):731-7. DOI: 10.1002/cncr.22835. View

5.
Davies H, Bignell G, Cox C, Stephens P, Edkins S, Clegg S . Mutations of the BRAF gene in human cancer. Nature. 2002; 417(6892):949-54. DOI: 10.1038/nature00766. View